In 2015 was created Regent Capital, which is appeared as VC. The main office of represented VC is situated in the Shenzhen. The company was established in Asia in China.
Considering the real fund results, this VC is 20 percentage points more often commits exit comparing to other organizations. The top activity for fund was in 2017. The fund is constantly included in less than 2 investment rounds annually. The common things for fund are deals in the range of 50 - 100 millions dollars.
The standard case for the fund is to invest in rounds with 4-5 partakers. Despite the Regent Capital, startups are often financed by Joy Capital, Gobi Partners, Vision Plus Capital. The meaningful sponsors for the fund in investment in the same round are Vision Plus Capital, Joy Capital, Gaorong Capital. In the next rounds fund is usually obtained by Tiger Global Management, Joy Capital, Gaorong Capital.
Among the most successful fund investment fields, there are Real Estate, Database. The fund has exact preference in some founders of portfolio startups. Moreover, a startup needs to be at the age of 2-3 years to get the investment from the fund. Among the various public portfolio startups of the fund, we may underline Chezhibao, Laoyuegou, Chedai.com For fund there is a match between the country of its foundation and the country of its the most frequent investments - China.
Related Funds
Funds with similar focus
Fund Name | Location |
Daicel | Chiba Prefecture, Japan, Tateyama |
Fuzhida Technology Consultation | China, Guangdong, Shenzhen |
Nextlaw Labs | California, Palo Alto, United States |
Northern Pacific Group | Minnesota, United States, Wayzata |
Ocean Avenue Capital | California, Santa Monica, United States |
ProtectCELL | Michigan, Novi, United States |
Tahseen Consulting | Dubai, United Arab Emirates |
Tamar Capital | New York, New York, United States |
Notable deals
Company | Industry | Round Size | Date | Investors | Location |
ITabMed | $20M | 01 Dec 2021 | Shanghai, Shanghai, China | ||
$100M | 30 Jun 2020 | Cambridge, Massachusetts, United States | |||
1KMXC | 27 May 2019 | Shangcheng District, Zhejiang, China | |||
01 Apr 2019 | China, Shanghai | ||||
Danke Apartment | $70M | 06 Jun 2018 | China, Beijing | ||
Danke Apartment | $100M | 26 Feb 2018 | Dongcheng District, Beijing, China | ||
Chezhibao | $77M | 16 Jun 2017 | China, Jiangsu | ||
06 Jan 2017 | Dongcheng District, Beijing, China | ||||
Laoyuegou | $10M | 01 Apr 2016 | China, Shanghai |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Latest deals
Company | Industry | Round Size | Date | Investors | Location |
ITabMed | $20M | 01 Dec 2021 | Shanghai, Shanghai, China | ||
$100M | 30 Jun 2020 | Cambridge, Massachusetts, United States | |||
1KMXC | 27 May 2019 | Shangcheng District, Zhejiang, China | |||
01 Apr 2019 | China, Shanghai | ||||
Danke Apartment | $70M | 06 Jun 2018 | China, Beijing | ||
Danke Apartment | $100M | 26 Feb 2018 | Dongcheng District, Beijing, China | ||
Chezhibao | $77M | 16 Jun 2017 | China, Jiangsu | ||
06 Jan 2017 | Dongcheng District, Beijing, China | ||||
Laoyuegou | $10M | 01 Apr 2016 | China, Shanghai |